Powered by: Motilal Oswal
2025-03-07 02:13:55 pm | Source: Accord Fintech
Entero Healthcare Solutions jumps on investing Rs 17 crore in Getwell
Entero Healthcare Solutions jumps on investing Rs 17 crore in Getwell

Entero Healthcare Solutions is currently trading at Rs. 1303.10, up by 30.90 points or 2.43% from its previous closing of Rs. 1272.20 on the BSE.

The scrip opened at Rs. 1263.85 and has touched a high and low of Rs. 1305.55 and Rs. 1263.85 respectively. So far 1294 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1583.00 on 07-Nov-2024 and a 52 week low of Rs. 974.45 on 28-Mar-2024.

Last one week high and low of the scrip stood at Rs. 1305.80 and Rs. 1205.00 respectively. The current market cap of the company is Rs. 5669.49 crore.

The promoters holding in the company stood at 52.44%, while Institutions and Non-Institutions held 30.98% and 16.59% respectively.

Entero Healthcare Solutions has invested Rs 17 crore in the equity shares issued by the Getwell Medicare Solutions (Getwell) on Rights basis. Consequently, equity shareholding of the Company in Getwell has been increased from 68,00,000 Equity Shares (85%) to 2,38,00,000 equity shares (95.20%). 

Entero Healthcare Solutions is a distributor of healthcare products in India. The company's technology-driven platform provides healthcare product distribution services to pharmacies, hospitals, and clinics throughout India.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here